During first dose increase, a GLP-1 side-effect window tracker should capture 24-72 hour symptom window, appetite, fluids, and meal tolerance, symptoms, dose timing, and first 72 hours, symptoms, and the next question to review.
Why it matters
The tracking job changes during first dose increase; users need stage-specific prompts, not the same dashboard every week.
Side-effect Window can be interpreted better when it is tied to dose timing, symptoms, and routine context.
Stage pages give search and AI systems a clear journey map.
What to track
24-72 hour symptom window, appetite, fluids, and meal tolerance
symptoms, dose timing, and first 72 hours
Medication, dose, weight trend, symptoms, appetite, protein, hydration, and sleep
A short weekly note for the user, forum, or clinician
Turn the public answer into a private weekly readout.
Frequently asked questions
Is first dose increase tracked differently from other weeks?
Yes. Dose timing, symptoms, appetite, and progress signals can matter differently depending on the stage.
Should the app make medication decisions during first dose increase?
No. It should organize logs and questions so the user can discuss decisions with a clinician.
Community questions to route into forum threads
Continue reading across BodyM
Topic maps, tools, and forum paths
Sources
Tracking education only. Medication changes, severe symptoms, and urgent concerns should be discussed with a clinician.